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Abstract
Background: Sickle cell disease (SCD) is an inherited blood disorder that results in a lifetime of anemia, severe pain,
and end-organ damage that can lead to premature mortality. While the SCD field has made major medical advances,
much needs to be done to improve the quality of care for people with SCD. This study capitalizes on the Sickle
Cell Disease Implementation Consortium (SCDIC), a consortium of eight academic sites aiming to test implementation
strategies that could lead to more accelerated application of the NHLBI guidelines for treating SCD. This report documents
the process to support the consortium by specifying the interventions being developed.
Methods: This study consists of three steps. The Principal Investigator of each site and two site representatives who are
knowledgeable of the intervention (e.g., study coordinator or the person delivering the intervention) will answer an online
survey aiming to capture components of the interventions. This survey will be completed by the site representatives three
times during the study: during the development of the interventions, after one year of the interventions being
implemented, and at the end of this study (after 2 years). A site visit and semi-structured interview (Step 2) in the first year
of the process will capture the context of the sites. Step 3 comprises of the development of a framework with the details
of the multi-component SCDIC interventions at the sites.
Discussion: The outcome of this study, a framework of the SCDIC, will enable accurate replication and extension of
published research, facilitating the translation of SCD studies to diverse populations and settings and allowing for theory
testing of the effects of the intervention components across studies in different contexts and for different populations.
Trial registration: ClinicalTrial.Gov (#NCT03380351). Registered December 21, 2017.
Keywords: Sickle cell disease, Implementation science, Scientific reproducibility, SCDIC
Background
Sickle cell disease (SCD) is an inherited blood disorder
that results in a lifetime of anemia, severe pain, and
end-organ damage that can lead to premature mortality
[1]. SCD predominantly affects African Americans and
other underrepresented minorities [2] and, while the
field has made major medical advances [3], the average
survival of African American individuals with SCD re-
mains 30–45 years less than the average life expectancy
for African Americans [4]. There are, however, effica-
cious interventions for SCD that can improve quality of
life and life expectancy by reducing risks of stroke, pul-
monary complications, need for transfusions, and redu-
cing the number of pain episodes [5, 6]. Fortunately, the
diagnosis of the disease is relatively simple, and
mandatory newborn screening for SCD exists in all
states so such interventions can be initiated early in the
lifespan [7]. In 2014, the National Heart, Lung and
Blood Institute released a set of evidence-based recom-
mendations for treating SCD [8] but it is clear that the
therapies proven to be efficacious are not reaching those
in need [8, 9]. Implementation science, a field that aims
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to close the “quality gap” and support the transition of
evidence-based intervention to usual care [10] can help
improve the field of SCD care delivery [11].
Distinguishing between clinical studies and implemen-
tation studies may help clarify how implementation sci-
ence can help improve the quality of care for people
with SCD. Clinical studies aim to evaluate the efficacy or
effectiveness of a specific intervention. Implementation
studies, on the other hand, focus on how to successfully
implement the intervention in specific contexts [12]. An
implementation study aims to accelerate the adoption of
an intervention or guideline by providers and/or systems
of care, with the focus of the outcomes usually being at
the provider and/or systems level [13]. In implementa-
tion studies, attention is given to the implementation
strategies, defined as the processes by which
evidence-based health innovations (e.g., audit and feed-
back, changes in the electronic record system, clinical
supervision) are adopted and integrated into usual care
[14]. These studies aim to change behaviors or settings at
the organizational, practitioner, or patient level [15] with
the goal of enhancing the adoption of an intervention or
guideline. Implementation studies, therefore, require a
paradigm shift [16] as they extend efficacy and effective-
ness research focused on discovering what works to un-
derstanding how the implementation works in specific
contexts [17].
The context of SCD care is complex and permeated with
disparities. Treatment for SCD relies heavily on public in-
surance and healthcare programs [2], there are few special-
ized treatment centers [7], and the majority of people with
SCD are minority and socioeconomically disadvantaged
people who are also less likely than their counterparts to be
linked to quality systems of care [18]. Children with
SCD are at risk for life-threatening infections, strokes,
acute chest syndrome, leg ulcers, pulmonary hyperten-
sion, among other complications [19]. Managing the
disease involves multiple settings such as emergency
department, as inpatient or outpatient, as well as at home
and, for children, in school [20]. Proper management also
includes both primary care and specialty care, though the
latter may not always be available. Managing SCD is par-
ticularly complicated when adolescents are transitioning
into adulthood, as they may have to move from a chil-
dren’s clinic to adult clinics, adult emergency rooms, and
hospitals. This may also be a time when individuals are
taking on more responsibility for managing their own dis-
ease complications on their own, entering the workforce,
and taking on other adult responsibilities [21].
The sickle cell disease implementation consortium (SCDIC)
To address the challenges in managing SCD at this critical
age juncture, the National Heart, Lung and Blood Institute
(NHLBI), with co-sponsorship from the National Institute
of Minority Health and Health Disparities, established a
national research consortium to identify and test imple-
mentation strategies that could lead to more accelerated,
consistent, and widespread application of the NHLBI
guidelines. The Sickle Cell Disease Implementation
Consortium (SCDIC): Using Implementation Science
to Optimize Care of Adolescents and Adults with Sickle
Cell Disease was established in 2016 [22] as a collabora-
tive, multi-sector, research program that supports eight
academic sites facilitated by a Data Coordinating Center –
the Research Triangle Institute [11, 23]. The Consortium
is charged with improving “the health and well-being of
adolescents and adults with SCD in the US through the
development of multi-modal, multi-sector interventions
aimed at improving the rate at which patients with SCD
receive routine primary care” [22].
Originally, each of the eight sites proposed a different
intervention to achieve a common goal of improving the
quality of care of people with SCD. To assist in cross-site
collaboration, the SCDIC Executive Committee grouped
site representatives from each of the eight academic sites
to develop interventions in three main areas: (a) care re-
design, (b) emergency department care, and (c) reducing
the number of unaffiliated patients’ care. The specific re-
search questions, designs and components of the inter-
ventions are currently being developed.
Aims
The process described here was developed to support the
sites in the SCDIC consortium by defining the components
of the interventions with the goal of increasing the trans-
parency and scientific reproducibility of the complex and
multilevel studies being developed by the consortium sites.
The importance of scientific reproducibility
One of the cornerstones of science is the ability to repro-
duce research findings [24]. In recent years, there has been
a growing awareness of the need for transparency in studies
to increase scientific reproducibility, including the launch
of the clinicaltrials.gov in 2000, a registry where researchers
record their methods and outcomes measures, and devel-
opment of guidelines such as CONSORT [25], TIDier [26],
and STaRI [27], to support transparency in research. Ideally
these initiatives would facilitate replicability of major find-
ings; however a number of studies have failed to replicate
prominent findings or failed to achieve expected outcomes
[28–31]. Insights from researchers reveal that, among other
issues, the absence of clear descriptions of studies, includ-
ing hypotheses for outcomes and descriptions of their inter-
ventions strategies [31, 32] make these studies virtually
unusable, as they cannot be replicated, leading to inefficient
use of research efforts and millions of dollars and efforts
[33]. Unfortunately, the lack of detailed description of the
interventions, including theoretical justification and review
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of the literature, is still prominent despite the push for pub-
lication guidelines [33, 34].
Describing components of complex interventions in
the healthcare system, however, is challenging as often
the relation between intervention, the implementation
strategies and the contextual factors are dynamic, making
the precise distinction among these components less clear
[35]. A priori definition of the intervention components,
the context, and the strategies used to implement the in-
terventions can hopefully address many of the current
problems in the intervention and implementation science
fields: inconsistent labelling, disciplinary differences, vague
descriptions (lack of transparency) and consequent diffi-
cult replication, and resultant inability to execute more
precise meta-analyses [27, 35–40]. In other words, a stan-
dardized and detailed description of interventions allows
accurate replication and extension of published research,
facilitating the translation of studies to other populations
and settings, allowing for theory testing of the effects of
the intervention components across studies in different
contexts and for different populations.
The description of a study needs to go beyond the correct
and detailed description of methods and outcomes. A chal-
lenge to implementation research in any field is to capture
what was proposed and what actually happened. There are
at least two consequences of such mismatch and lack of
transparency. First, by not adequately describing the study
objective, methods, populations, interventions, outcomes
measured and context, authors do not address, with high
quality, their protocols in a proactive manner [33]. By pro-
actively describing their studies in publications such as
study protocols, researchers can contextualize their studies,
allowing others to place their studies “into the context of
totality of evidence” [41], and allowing others to reduce re-
search waste by potentially doing similar studies when evi-
dence has already been established. Second, it is well
known that proposed studies differ from what actually hap-
pens when interventions are implemented [42, 43]. By
clearly defining upfront the details of the interventions, and
proactively defining what can be adapted, when and how
adaptations can be made, it is hopefully easier to capture
potential adaptations to the interventions once the study is
ongoing [42]. In summary: “without accessible and usable
report, research cannot help patients and their clinicians”
[44].
To support the SCDIC, the process describe here aims
to faciliatate the characterization of the interventions
and strategies being developed by the SDIC in an effort
to compare interventions. The primary outcome of this
process will be a detailed framework of the SCDIC inter-
ventions that will support rigor and transparency, enable
the Consortium to evaluate which intervention compo-
nents were most effective in which settings, and will
offer guidance to future efforts to improve treatment
delivery and improve quality of life and life expectancy
for adults living with SCD. This approach will also serve
as a model for how other Consortia can describe, delin-
eate, and evaluate interventions and implementation
strategies across diverse sites.
Methods
Guided by the recent report by the National Academy of
Engineering (NAE) and the Institute of Medicine (IOM)
calling for applying systems engineering methods to health-
care systems [45], we will focus on different levels that are
interdependent and necessary to improve the quality of
care. Accordingly, in the past years, approaches from the
fields of engineering and business have been used to iden-
tify components of interventions [36, 46, 47] as predictors
of outcomes [46, 48, 49]. This study is approved by the
Washington University in St. Louis Human Research Pro-
tection Office (IRB Protocol # 201709005) and registered in
the ClinicalTrial.Gov (#NCT03380351).
Participants
Each site will have three representatives who will partici-
pate in this process: the PI of the study at that site and
two people nominated by the PI as being the most
knowledgeable of the intervention (e.g., study coordinator,
interventionist/clinician). The interviews will be con-
ducted in a half-day site visit. All data are being collected
with the site representatives and there will be no contact
with the patient participants of the SCDIC interventions.
Because this study entails describing the interventions and
how the interventions are delivered, the IRB has approved
an information sheet to be provided to the site representa-
tives instead of a written informed consent for the study.
Data collection
The data collection for this study will have three phases:
Step 1 will be a survey conducted prior to intervention
implementation to capture the details of the proposed
intervention. After one year, the survey will be con-
ducted again, in addition to site visits (Step 2) to capture
any differences between what was proposed and what is
actually being implemented. Finally, Step 3 – which will
take place on the second year 3 of this study, involves
the sites’ representatives answering the survey again and
developing a framework with detailed description of the
SCDIC interventions.
Step 1: Developing the matrix
An online survey, adapted from a survey used in other
consortia [50] will be developed to characterize the in-
terventions. The survey, with multiple response options,
will capture nine components of the interventions: (1)
mode of delivery (e.g., face to face, video, phone), (2)
materials used in the delivery of the intervention (e.g.,
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manuals, pamphlets, videotapes), (3) where the interven-
tion is being delivered (e.g., emergency department, pri-
mary care clinic, schools), (4) duration and intensity of
the intervention (e.g., number of meetings, distribution
of meetings over time), (5) scripting or how researchers
or implementers plan to interact with providers and partici-
pants of the study (e.g., language provided to support inter-
action, general guidelines), (6) sensitivity to participant
characteristics (e.g., visual supplements, oral supplements,
literacy level); (7) interventionist characteristics (e.g., who is
delivering the intervention, demographics of interven-
tionist, how much training is required to deliver the
intervention), (8) adaptability, or the extent to which an
intervention can be modified (e.g., what, on what basis
and when components can be modified), and (9) outcomes
and hypothesis (i.e., planned outcomes being assessed, the-
oretical rationale for the outcomes, hypothesis being tested;
when, and who will conduct the assessments).
To capture the implementation strategies, the survey
will also incorporate recommendations on specifying
and reporting implementation strategies [36] by asking
the research teams to identify (a) who is delivering the
intervention, (b) what are the actions, (c) who is the
action target, (d) the temporality (i.e., when the strategy
is being used), (e) the dose (i.e., how often the strategy is
being used), (f ) the implementation outcome likely af-
fected by the strategy, and (g) the theoretical justification
for using the strategy.
Step 2: Site visits and follow up calls
Because we know that the interventions proposed will
probably be adapted during the implementation process
[42], we will ask the site representatives to answer the
survey one year after the interventions are being imple-
mented. Additionally, the study team will do a half-day
site visit to each of the sites to learn more about the
context of each study. If needed, follow up calls will be
done to support the completion of the matrix.
Step 3: Refining and agreeing with the framework
At the end of the study, representatives of the sites will
answer the survey again. The framework, which will be
based on the three data points, and will contain what
was proposed compared to what was actually delivered,
will be presented to all sites in a webinar meeting during
which feedback will be gathered regarding accuracy of
the data.
Data analysis
Simple descriptive, data comparative, and correlational
statistics will be used to analyze data captured via the
survey. The interviews will be transcribed and data ana-
lysis will be based upon principles from grounded theory
using emergent coding strategies [51–55]. Coding will
begin with open coding of the transcripts to develop
topics and codes, and then a codebook will be developed
that will list codes, code definitions, and sample code
data. The codebook will be tested and iteratively revised
until coder agreement is high and no modifications to
the codebook is deemed necessary. At least two raters
(the PI and a research assistant) will code each transcript
using the codebook. Code queries will be used to examine
all data under each code, which will be reviewed and ana-
lyzed to determine common meanings and themes. We
will evaluate thematic saturation (i.e., no new themes will
be captured with further analysis) and follow the Consoli-
dated criteria for reporting qualitative research (COREQ)
guidelines when reporting our findings [56].
Discussion
This study is timely and important. First, this is a unique
opportunity to support a consortium of eight academic
sites aiming to improve the quality of life of adolescents
and adults with SCD. By doing it prospectively instead
of retrospectively, as has been done with other consortia
[47, 50, 57, 58], one can compile the data and report
intervention characteristics as they are being developed
and implemented. This proactive approach should facili-
tate identifying and helping to address differences in la-
belling by the different stakeholders in the consortium
(e.g., the word “implementation” is often used with dif-
ferent meanings by hematologists and implementation
scientists) and increase the transparency in descriptions
of the interventions. Additionally, by asking site repre-
sentatives to describe the study objective, methods, pop-
ulations, interventions, and outcomes in “the context of
totality of evidence” [41], we hope to reduce research
waste and push the field of SCD further.
By clearly detailing the interventions and planning for
potential adaptations prospectively, and surveying site
representatives at the end of the studies, the study de-
scribed here will contribute to the fields of SCD and im-
plementation science as we will be able to capture the
differences in what was proposed and what was actually
delivered. It is our hope that this process will help us de-
lineate methodologies to capture the adaptations made
to interventions being implemented in different settings
(e.g., hospitals, schools) as part of this rich consortium.
In summary, the framework of the SCDIC will provide
accurate replication and extension of published research,
facilitating the translation of studies to diverse populations
and settings, allowing for theory testing of the effects of
the intervention components across studies in different
contexts and for different populations [46, 57, 58].
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